ALHAMBRA, Calif., June 14, 2021 /PRNewswire/ -- Apollo Medical
Holdings, Inc. ("ApolloMed," and together with its subsidiaries and
affiliated entities, the "Company") (NASDAQ: AMEH), a leading
physician-centric, technology-powered healthcare company focused on
enabling providers in the successful delivery of value-based care,
today announced that it will be added to the S&P SmallCap 600
index, effective prior to the opening of trading on Tuesday, June 15, 2021. The S&P SmallCap 600
seeks to measure the small-cap segment of the U.S. equity market
and consists of 600 domestic stocks selected by Standard &
Poor's Index Committee based on several factors, including
financial performance and market capitalization.
Kenneth Sim, M.D., Executive
Chairman and Co-Chief Executive Officer of ApolloMed, stated,
"ApolloMed's addition to the S&P SmallCap 600 is a testament to
our commitment to long-term growth and exceptional financial
performance as the leader in value-based healthcare management and
provider enablement. Our inclusion is an absolute honor that we
expect will increase our visibility within the investment community
and enhance shareholder value as we continue to execute on our
vision and nationwide growth strategy."
For more information on the S&P SmallCap 600 and S&P Dow
Jones Indices, please visit www.spdji.com.
About Apollo Medical Holdings, Inc.
ApolloMed is a
leading physician-centric, technology-powered, risk-bearing
healthcare company. Leveraging its proprietary end-to-end
technology solutions, ApolloMed operates an integrated healthcare
delivery platform that enables providers to successfully
participate in value-based care arrangements, thus empowering them
to deliver high quality care to patients in a cost-effective
manner.
Headquartered in Alhambra,
California, ApolloMed's subsidiaries and affiliates include
management services organizations (MSOs), affiliated independent
practice associations (IPAs) and a Next Generation Accountable Care
Organization (NGACO). For more information, please visit
www.apollomed.net.
Forward Looking Statements
This press release
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, such as statements
about ApolloMed's investment in, strategic arrangements with, and
anticipated consolidation of, Sun
Labs, and ApolloMed's and Sun
Labs' growth, acquisition strategy, ability to deliver
sustainable long-term value, operational focus, strategic growth
and expansion plans and integration efforts. Forward-looking
statements reflect current views with respect to future events and
financial performance and therefore cannot be guaranteed. Such
statements are based on the current expectations and certain
assumptions of ApolloMed's management, and some or all of such
expectations and assumptions may not materialize or may vary
significantly from actual results. Actual results may also vary
materially from forward-looking statements due to risks,
uncertainties and other factors, known and unknown, including the
risk factors described from time to time in ApolloMed's reports
filed with the Securities and Exchange Commission, including,
without limitation, the risk factors contained in ApolloMed's
Annual Report on Form 10-K for the year ended December 31, 2020, and any subsequent Quarterly
Reports on Form 10-Q.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor
Relations
(626) 943-6491
investors@apollomed.net
Carolyne Sohn, The Equity
Group
(415) 568-2255
csohn@equityny.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-to-join-sp-smallcap-600-301311265.html
SOURCE Apollo Medical Holdings, Inc.